Barcelona, Spain

Félix Cuevas-Cordobes


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Félix Cuevas-Cordobes

Introduction

Félix Cuevas-Cordobes is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on tricyclic triazolic compounds. His research focuses on compounds that exhibit a high affinity for the sigma-1 receptor, which has important implications for the development of new medicaments.

Latest Patents

Félix Cuevas-Cordobes holds a patent for his invention titled "Tricyclic triazolic compounds." This patent describes new compounds that are characterized by their unique structure and potential therapeutic applications. The compounds are defined by a specific formula, where R and R' are detailed in the patent description. This innovation represents a significant advancement in the search for effective treatments targeting the sigma-1 receptor.

Career Highlights

Throughout his career, Cuevas-Cordobes has worked with esteemed organizations, including Laboratories Del Dr. Esteve S.A. His experience in these companies has allowed him to collaborate with other professionals in the field and contribute to various research projects. His work has been instrumental in advancing the understanding of triazolic compounds and their applications in medicine.

Collaborations

Félix Cuevas-Cordobes has collaborated with notable colleagues such as Miguel Angel Pericas-Brondo and Antoni Torrens-Jover. These collaborations have enriched his research and have led to further innovations in the field of medicinal chemistry.

Conclusion

Félix Cuevas-Cordobes is a distinguished inventor whose work on tricyclic triazolic compounds has the potential to impact the development of new therapeutic agents. His contributions to the field highlight the importance of innovation in medicine and the ongoing quest for effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…